This report will:
- Provide an overview of the monoclonal antibody (mAbs) industry: market value, key on the future of antibody-based drug players, opportunities and the future
- Explore what’s next for antibody-based drugs and where the opportunity is coming from
- Include an interview Bio-Rad’s John Cardone, who shares expertise on the future of antibody-based drug discovery
- Share significant future trends for the therapeutic antibody market